...
eyen-img

Eyenovia Inc, Common Stock

EYEN

NAQ

$0.0845

+$0

(0%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.50M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
9.51M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.75
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.08 L
$2.57 H
$0.0845

About Eyenovia Inc, Common Stock

Eyenovia, Inc., a commercial-stage ophthalmic pharmaceutical technology company, engages in developing a pipeline of microdose array print therapeutics. It focuses on commercializing Mydcombi (tropicamide and phenylephrine HCL ophthalmic spray) for inducing mydriasis for routine diagnostic procedures and in conditions where short term pupil dilation is desired, and clobetasol propionate ophthalmic suspension for the treatment of post-operative pain and inflammation following ocular surgery. The company is also developing the Optejet delivery system for use in combination with its drug-device therapeutic programs and for out-licensing for use in combination with therapeutics for additional indications. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company has agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameEYENSectorS&P500
1-Week Return3.55%-0.94%-2.6%
1-Month Return-4.95%-5.08%-1.08%
3-Month Return-81.54%-10.62%3.45%
6-Month Return-87.29%-6.18%8.57%
1-Year Return-95.73%1.98%24.3%
3-Year Return-97.95%-0.93%25.58%
5-Year Return-97.75%33.84%84.07%
10-Year Return-99.15%102.52%185.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-2.00M14.00M10.00M3.79K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":14.29,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":71.43,"profit":true},{"date":"2023-12-31","value":0.03,"profit":true}]
Cost of Revenue15.34K800.00K1.60M307.43K3.79K[{"date":"2019-12-31","value":0.96,"profit":true},{"date":"2020-12-31","value":50,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":19.21,"profit":true},{"date":"2023-12-31","value":0.24,"profit":true}]
Gross Profit(15.34K)1.20M12.40M(307.43K)(783.21K)[{"date":"2019-12-31","value":-0.12,"profit":false},{"date":"2020-12-31","value":9.68,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2.48,"profit":false},{"date":"2023-12-31","value":-6.32,"profit":false}]
Gross Margin-60.00%88.57%(3.07%)(20681.49%)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":67.74,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-3.47,"profit":false},{"date":"2023-12-31","value":-23350.07,"profit":false}]
Operating Expenses21.31M20.98M25.30M26.91M25.41M[{"date":"2019-12-31","value":79.18,"profit":true},{"date":"2020-12-31","value":77.96,"profit":true},{"date":"2021-12-31","value":94.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.41,"profit":true}]
Operating Income(21.31M)(19.78M)(12.90M)(26.91M)(25.41M)[{"date":"2019-12-31","value":-2130854400,"profit":false},{"date":"2020-12-31","value":-1977922500,"profit":false},{"date":"2021-12-31","value":-1290368300,"profit":false},{"date":"2022-12-31","value":-2691151500,"profit":false},{"date":"2023-12-31","value":-2540644600,"profit":false}]
Total Non-Operating Income/Expense303.57K28.72K(259.94K)(2.40M)(3.90M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":9.46,"profit":true},{"date":"2021-12-31","value":-85.63,"profit":false},{"date":"2022-12-31","value":-789.39,"profit":false},{"date":"2023-12-31","value":-1285.55,"profit":false}]
Pre-Tax Income(21.16M)(19.77M)(12.78M)(28.01M)(27.26M)[{"date":"2019-12-31","value":-2115675800,"profit":false},{"date":"2020-12-31","value":-1976986700,"profit":false},{"date":"2021-12-31","value":-1277838700,"profit":false},{"date":"2022-12-31","value":-2801115700,"profit":false},{"date":"2023-12-31","value":-2726109600,"profit":false}]
Income Taxes(167.13K)(78.37K)213.38K(280.42K)2.00[{"date":"2019-12-31","value":-78.33,"profit":false},{"date":"2020-12-31","value":-36.73,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-131.42,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(20.99M)(19.69M)(12.99M)(27.73M)(27.26M)[{"date":"2019-12-31","value":-2098962900,"profit":false},{"date":"2020-12-31","value":-1969149400,"profit":false},{"date":"2021-12-31","value":-1299176300,"profit":false},{"date":"2022-12-31","value":-2773074100,"profit":false},{"date":"2023-12-31","value":-2726109800,"profit":false}]
Income From Continuous Operations(21.16M)(19.77M)(12.78M)(28.01M)(25.42M)[{"date":"2019-12-31","value":-2115675800,"profit":false},{"date":"2020-12-31","value":-1976986700,"profit":false},{"date":"2021-12-31","value":-1277838700,"profit":false},{"date":"2022-12-31","value":-2801115700,"profit":false},{"date":"2023-12-31","value":-2541735500,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(20.99M)(19.69M)(12.99M)(27.73M)(27.26M)[{"date":"2019-12-31","value":-2098962900,"profit":false},{"date":"2020-12-31","value":-1969149400,"profit":false},{"date":"2021-12-31","value":-1299176300,"profit":false},{"date":"2022-12-31","value":-2773074100,"profit":false},{"date":"2023-12-31","value":-2726109600,"profit":false}]
EPS (Diluted)(1.54)(0.96)(0.51)(0.84)(0.67)[{"date":"2019-12-31","value":-154,"profit":false},{"date":"2020-12-31","value":-96,"profit":false},{"date":"2021-12-31","value":-51,"profit":false},{"date":"2022-12-31","value":-84,"profit":false},{"date":"2023-12-31","value":-67,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

EYEN
Cash Ratio 0.46
Current Ratio 0.74
Quick Ratio 0.55

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

EYEN
ROA (LTM) -92.94%
ROE (LTM) -914.66%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

EYEN
Debt Ratio Lower is generally better. Negative is bad. 0.84
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.16

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

EYEN
Trailing PE NM
Forward PE NM
P/S (TTM) 302.64
P/B 2.61
Price/FCF NM
EV/R 487.83
EV/Ebitda NM

FAQs

What is Eyenovia Inc share price today?

Eyenovia Inc (EYEN) share price today is $0.0845

Can Indians buy Eyenovia Inc shares?

Yes, Indians can buy shares of Eyenovia Inc (EYEN) on Vested. To buy Eyenovia Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EYEN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Eyenovia Inc be purchased?

Yes, you can purchase fractional shares of Eyenovia Inc (EYEN) via the Vested app. You can start investing in Eyenovia Inc (EYEN) with a minimum investment of $1.

How to invest in Eyenovia Inc shares from India?

You can invest in shares of Eyenovia Inc (EYEN) via Vested in three simple steps:

  • Click on Sign Up or Invest in EYEN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Eyenovia Inc shares
What is Eyenovia Inc 52-week high and low stock price?

The 52-week high price of Eyenovia Inc (EYEN) is $2.57. The 52-week low price of Eyenovia Inc (EYEN) is $0.08.

What is Eyenovia Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Eyenovia Inc (EYEN) is

What is Eyenovia Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Eyenovia Inc (EYEN) is 2.61

What is Eyenovia Inc dividend yield?

The dividend yield of Eyenovia Inc (EYEN) is 0.00%

What is the Market Cap of Eyenovia Inc?

The market capitalization of Eyenovia Inc (EYEN) is $9.50M

What is Eyenovia Inc’s stock symbol?

The stock symbol (or ticker) of Eyenovia Inc is EYEN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top